|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, April 30, 2016 ) Going forward in the 5EU Region Viscosupplementation Industry Report, palliative pain treatments are likely to continue to fare well as healthcare reform kicks in and lag times for knee replacement become the norm.
The increasing prevalence of OA and the lower cost of prescribing viscosupplementation compared with knee replacement surgery have prompted the medical community to take a closer look at this therapy. However, there is a growing concern among physicians that the updated American Academy of Orthopaedic Surgeons (AAOS) and Osteoarthritis Research Society International (OARSI) treatment guidelines for knee OA will result in increased insurance denials for viscosupplementation. Moving forward, industry consolidation and intense competition in the viscosupplementation arena will cause increasing numbers of companies to augment their research efforts to differentiate their products from the lower-end competitors. The motivation to incorporate the favorable properties of different agents into a more effective viscosupplementation product has led to the manipulation and development of next-generation HA formulations consisting of not only HAs, but also pharmaceuticals, such as corticosteroids.
Other Key Points in Report:
- Future growth in the viscosupplementation market lies in the one-injection segment. What are the current adoption trends in different geographies? How will one-injection segment drive the market revenue growth in the upcoming years?
- Reimbursement is the single greatest barrier to the market growth for viscosupplementation procedures. How does the current payer mix look like in different countries?
- In recent years, there has been an expansion in the use of intra-articular HA viscosupplementation for treating OA at hips, shoulders, and other small joints. What are the current adoption trends in different regions?
- Because the most prevalent treatment regimen varies from region to region, the competitive landscape in the viscosupplementation space can be quite different across the geographies covered in this report. Who are the leading players in the viscosupplementation market in different countries?
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001178680/buying
Table of Content: An Overview
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Treatment Modalities Overview
3.1 Treatment Paradigm
3.1.1 Physical Therapies
3.1.2 Medications
3.1.3 Hyaluronic Acid Viscosupplementation
3.1.4 Surgical Intervention
4 Industry Overview
4.1 Procedural Trends
4.2 Market Access
4.3 Reimbursement
4.4 Mergers and Acquisitions/Key Partnerships
4.4.1 Meda AB Acquires Rottapharm|Medaus for $3.1 Billion (October 2014)
4.4.2 Founders of Anteis Establish Aptissen (March 2014)
4.4.3 Bioventus Acquires Durolane Assets from Galderma (February 2014)
4.4.4 Zimmer to Combine with Biomet in a Transaction Valued at $13.35 Billion (April 2014)
4.4.5 Johnson & Johnson Acquires Synthes for $19.7 Billion (June 2012)
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001178680/discount
5 Market Drivers, Opportunities, and Barriers
5.1 Driver: Rising Prevalence of OA
5.2 Driver: Multimodal Treatment Paradigm for OA
5.3 Driver: Viscosupplementation Delays Total Knee Replacement
5.4 Driver: Side Effects of NSAIDs, Corticosteroids, and Narcotics
5.5 Driver: Direct-To-Consumer Marketing
5.6 Opportunity: Expanding Indications
5.7 Opportunity: New-Generation HA Derivatives
5.8 Opportunity: Increased Use After Arthroscopic Surgeries
5.9 Opportunity: Self-Pay Market
5.10 Opportunity: Emerging Countries
5.11 Barrier: Unfavorable Reimbursement Scenario
5.12 Barrier: Pricing Erosion
5.13 Barrier: Cost-Effective Pharmacological Therapies
5.14 Barrier: Will The Rising Popularity of PRP Injection Impact the Viscosupplementation Market?
5.15 Barrier: Cost-Conscious Patients in Emerging Countries
6 Unmet Needs
6.1 Lack of Consensus on Clinical Efficacy of Viscosupplementation in Knee OA
6.2 Insufficient Evidence to Prove the Clinical Efficacy of Viscosupplementation in Other Joints
6.3 Better Understanding of the Basic Science
6.4 Ultrasound-Guided Injection
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001178680/buy/4450
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Email: sales@reportsweb.com
Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
